Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [522]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Reducing recurrence of advanced melanoma with pembrolizumab
Prof Alex Eggermont - Paris-Sud University, Paris, France
Reducing recurrence of advanced melanoma with pembrolizumab ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Prof Alex Eggermont - Paris-Sud University, Paris, France
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab. ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Lenalidomide with rituximab for mantle cell lymphoma
Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New...
Lenalidomide with rituximab for mantle cell lymphoma ( Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New York, USA )
11 Dec 2017
A biological perspective for personalising immunotherapies
Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK
A biological perspective for personalising immunotherapies ( Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK )
6 Dec 2017
Editor's Choice for November 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for November 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Dec 2017
The promise of immunotherapy for elderly patients
Dr Alistair Greystoke - Newcastle University, Newcastle, UK
The promise of immunotherapy for elderly patients ( Dr Alistair Greystoke - Newcastle University, Newcastle, UK )
15 Nov 2017
Adoptive cell therapy for solid tumours
Dr Sophie Papa - Guy's Hospital, London, UK
Adoptive cell therapy for solid tumours ( Dr Sophie Papa - Guy's Hospital, London, UK )
18 Oct 2017
BRIM8: Vemurafenib in high risk melanoma patients
Dr Karl Lewis - University of Colorado Denver, Colorado, USA
BRIM8: Vemurafenib in high risk melanoma patients ( Dr Karl Lewis - University of Colorado Denver, Colorado, USA )
11 Sep 2017
COMBI-AD: Dabrafenib plus trametinib in advanced melanoma
Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
COMBI-AD: Dabrafenib plus trametinib in advanced melanoma ( Dr Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )
11 Sep 2017
Expert commentary on melanoma immunotherapy latest
Dr Jeffrey Weber, Dr Axel Hauschild, Dr Dummer Reinhard
Expert commentary on melanoma immunotherapy latest ( Dr Jeffrey Weber, Dr Axel Hauschild, Dr Dummer Reinhard )
11 Sep 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation